At present, there are no approved antiviral drugs for Nipah and supportive care is the only option for human infections.

May 30, 2023: Artificial virus-like particle could be harnessed to improve human health (Nanowerk News) International researchers have built artificial virus-like particles capable of entering human ...

The virus-like particle chikungunya vaccine received accelerated approval from the FDA in February, and is one of two single-dose vaccines to prevent disease caused by the chikungunya virus.

A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV. Skip to main content. Your source for the latest research news.

CINCINNATI, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational ...

Pepper the cat, whose owner works at the University of Florida, gathered a specimen containing a never-before-seen virus for ...

Researchers have discovered that virus-like nanoparticles can promote the multicellular organization and reproduction of host bacteria. These particles, which are evolutionarily related to phages ...

The virus-like particle chikungunya vaccine received accelerated approval from the FDA in February, and is one of two single-dose vaccines to prevent disease caused by the chikungunya virus.

Touching Base is the dynamic podcast series from the editors of GEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex ...

The virus-like particle technology will be engineered and functionalized for the specific carcinoma cell type using therapeutically validated AAVs, including a novel primer compound. Hovione will be ...

Stranger still, we found that PEG10 behaves like a virus, too. It can form a virus-like particle, and it cleaves itself into smaller pieces like some viruses do.